Cohance Lifesciences Limited
COHANCE
Pozycja w akcjach
#6379
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Cena akcji
$5.05
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$1.93B
Zmiana (1 dzień)
-1.44%
Zmiana (1 rok)
-57.38%
Kraj
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategoria
Healthcare
Historia stopy dywidendy dla Cohance Lifesciences Limited (COHANCE)
Stopa dywidendy (TTM) dla Cohance Lifesciences Limited (symbol akcji: COHANCE) na dzień 2024-03-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.51%
Średnia stopa dywidendy z ostatnich 5 lat: 0.51%
Historia stopy dywidendy dla Cohance Lifesciences Limited (COHANCE) od 2019 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 1.69% | 160.00% |
| 2022 | 0.65% | 225.00% |
| 2021 | 0.20% | -93.33% |
| 2020 | 3.00% | 455.56% |
| 2019 | 0.54% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
